Home ▶ Vol 7, No 2 (2018) ▶ Ismail

 

1. Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda
Willy Ssengooba, Kevin Komakech, Sharon Namiiro, Henry Byabajungu, Joanitah Nalunjogi, Winceslaus Katagira, Ivan Kimuli, Moses L Joloba, Susan Adakun, Lydia Nakiyingi, Gabriela Torrea, Bruce J Kirenga
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases  vol: 25  first page: 100286  year: 2021  
doi: 10.1016/j.jctube.2021.100286

2. Multidrug-resistant tuberculosis: latest opinions on epidemiology, rapid diagnosis and management
Peter S. Nyasulu, Cheick Oumar Doumbia, Veranyuy Ngah, Antieme Combo Georges Togo, Bassirou Diarra, Gershom Chongwe
Current Opinion in Pulmonary Medicine  vol: 30  issue: 3  first page: 217  year: 2024  
doi: 10.1097/MCP.0000000000001070

3. Molecular epidemiological typing of M. tuberculosis isolates isolated from Turkey's Eastern Anatolia with in house PCR method
Elif AYDIN, Gülnur TARHAN, Funda ŞAHİN, Sami EREN
Cukurova Medical Journal  vol: 47  issue: 1  first page: 191  year: 2022  
doi: 10.17826/cumj.997873

4. Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
Joseph Baruch Baluku, Martin Nabwana, Joanitah Nalunjogi, Winters Muttamba, Ivan Mubangizi, Lydia Nakiyingi, Willy Ssengooba, Ronald Olum, Felix Bongomin, Irene Andia-Biraro, William Worodria
BMC Cardiovascular Disorders  vol: 22  issue: 1  year: 2022  
doi: 10.1186/s12872-022-02889-y

5. Identification of potential compounds for the management of multidrug-resistant tuberculosis using computational methods
Winnie Gatwiri, Richard Kagia
F1000Research  vol: 12  first page: 298  year: 2023  
doi: 10.12688/f1000research.130024.1

6. Pharmacogenetics as part of recommended precision medicine for tuberculosis treatment in African populations: Could it be a reality?
Carola Oelofse, Carene Anne Alene Ndong Sima, Marlo Möller, Caitlin Uren
Clinical and Translational Science  vol: 16  issue: 7  first page: 1101  year: 2023  
doi: 10.1111/cts.13520

7. Recurrent pneumothorax in a human immunodeficiency virus-positive patient with multidrug-resistant tuberculosis: a rare case of bronchopleural fistula: a case report
Lydia Nakiyingi, Joseph Baruch Baluku, Willy Ssengooba, Sharon Miriam Namiiro, Paul Buyego, Ivan Kimuli, Susan Adakun
Journal of Medical Case Reports  vol: 16  issue: 1  year: 2022  
doi: 10.1186/s13256-022-03436-1

8. Incidence and predictors of mortality among persons receiving second-line tuberculosis treatment in sub-Saharan Africa: A meta-analysis of 43 cohort studies
Dumessa Edessa, Fuad Adem, Bisrat Hagos, Mekonnen Sisay, Olivier Neyrolles
PLOS ONE  vol: 16  issue: 12  first page: e0261149  year: 2021  
doi: 10.1371/journal.pone.0261149

9. Determinants of Multidrug-Resistant Mycobacterium tuberculosis Infection: A Multicenter Study from Southern Ethiopia
Abdulkerim Badgeba, Mulugeta Shegaze Shimbre, Mathewos Alemu Gebremichael, Biruk Bogale, Menur Berhanu, Hanan Abdulkadir
Infection and Drug Resistance  vol: Volume 15  first page: 3523  year: 2022  
doi: 10.2147/IDR.S363628

10. Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana
Tuelo Mogashoa, Pinkie Melamu, Brigitta Derendinger, Serej D. Ley, Elizabeth M. Streicher, Thato Iketleng, Lucy Mupfumi, Margaret Mokomane, Botshelo Kgwaadira, Goabaone Rankgoane-Pono, Thusoyaone T. Tsholofelo, Ishmael Kasvosve, Sikhulile Moyo, Robin M. Warren, Simani Gaseitsiwe
Pathogens  vol: 8  issue: 4  first page: 208  year: 2019  
doi: 10.3390/pathogens8040208

11. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya
Martin O. Ogwang, Mabel Imbuga, Caroline Ngugi, Lucy Mutharia, Gabriel Magoma, Lamec Diero
BMC Infectious Diseases  vol: 21  issue: 1  year: 2021  
doi: 10.1186/s12879-021-06887-x

12. Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
Aynias Seid, Yilak Girma, Ayenesh Abebe, Eseye Dereb, Meseret Kassa, Nega Berhane
Infection and Drug Resistance  vol: Volume 16  first page: 3829  year: 2023  
doi: 10.2147/IDR.S412951

13. Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications
Qamar Niaz, Brian Godman, Stephen Campbell, Dan Kibuule
International Journal of Clinical Pharmacy  vol: 42  issue: 4  first page: 1227  year: 2020  
doi: 10.1007/s11096-020-01056-7

14. Predicting Treatment Outcomes in Patients with Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection, Using Supervised Machine Learning Algorithm
Mojisola Clara Hosu, Lindiwe Modest Faye, Teke Apalata
Pathogens  vol: 13  issue: 11  first page: 923  year: 2024  
doi: 10.3390/pathogens13110923

15. Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya
Albert Okumu, James Orwa, Ruth Sitati, Isaiah Omondi, Ben Odhiambo, Jeremiah Ogoro, George Oballa, Benjamin Ochieng, Steve Wandiga, Collins Ouma
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases  vol: 37  first page: 100466  year: 2024  
doi: 10.1016/j.jctube.2024.100466

16. Frailty modelling for multidrug-resistant tuberculosis mortality in Namibia
Opeoluwa Oyedele, Paulina Mweshitya Shikongo
Journal of Public Health Research  vol: 14  issue: 2  year: 2025  
doi: 10.1177/22799036251336969

17. High Prevalence of Rifampicin Resistance Associated with Rural Residence and Very Low Bacillary Load among TB/HIV‐Coinfected Patients at the National Tuberculosis Treatment Center in Uganda
Joseph Baruch Baluku, Pallen Mugabe, Rose Mulwana, Sylvia Nassozi, Richard Katuramu, William Worodria, Frederick D. Quinn
BioMed Research International  vol: 2020  issue: 1  year: 2020  
doi: 10.1155/2020/2508283

18. Molecular Detection of Drug-Resistant Mycobacterium tuberculosis in Sputum Specimens from the New and Previously Treated Tuberculosis Cases at the National Reference Chest Diseases Laboratory in Lusaka, Zambia
DK Mumena, G Kwenda , CW Ngugi , AK Nyerere
Journal of Biomedical Research & Environmental Sciences  vol: 2  issue: 4  first page: 232  year: 2021  
doi: 10.37871/jbres1218

19. Global trajectory and spatiotemporal epidemiological landscape of multidrug-resistant tuberculosis of spanning 46 years (1990–2035): implications for achieving global end TB goals
Yunbin Yang, Aoran Yang, Renzhong Li, Wei Su, Jiawen Jiang, Liangli Liu, Yunzhou Ruan, Lin Xu
Frontiers in Public Health  vol: 13  year: 2025  
doi: 10.3389/fpubh.2025.1660984

20. Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa
Jean Paul Sinumvayo, Pierre Celestin Munezero, Adegboyega Taofeek Tope, Rasheed Omotayo Adeyemo, Muritala Issa Bale, Jean Baptiste Nyandwi, Vetjaera Mekupi Haakuria, Leon Mutesa, Ahmed Adebowale Adedeji
Vaccines  vol: 12  issue: 7  first page: 741  year: 2024  
doi: 10.3390/vaccines12070741

21. Global, regional and national trends in tuberculosis incidence and main risk factors: a study using data from 2000 to 2021
Wentao Bai, Edward Kwabena Ameyaw
BMC Public Health  vol: 24  issue: 1  year: 2024  
doi: 10.1186/s12889-023-17495-6

22. Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK’s Training and Mentoring Pilot Project in the Abidjan Region
Yolanda Guerra Mendoza, Viviane Jusot, Félix Adou, Martin Ota, Diego Mpia Elenge, Tasim Begum, Nkululeko Mdladla, Olga Menang, Jean Claude Yavo, Mamadou Kamagaté
Drug Safety  vol: 47  issue: 2  first page: 147  year: 2024  
doi: 10.1007/s40264-023-01368-3

23. Risk factors and treatment outcomes of drug-resistant tuberculosis among patients attending Ndola teaching hospital in Ndola, Zambia: a retrospective case control study
Ricardo Mckees, Jonathan Gwasupika, Ruth Lindizyani Mfune, Clyde Moono Hakayuwa, Mathias Tembo, Chapline Shike Kalasa, Samuel Mwabafu, Ngula Monde, Imukusi Mutanekelwa, Namaunga Kasumu, Maisa Kasanga, Comfort Asante, Steward Mudenda, Victor Daka
Pan African Medical Journal  year: 2026  
doi: 10.11604/pamj.2026.53.84.50004

24. Bir Verem Savaş Dispanserine Kayıtlı Hastalardan İzole Edilen Mycobacterium Tuberculosis Suşlarında İlaç Duyarlılık Testleri Sonuçlarının Değerlendirilmesi
Ahmet Önder PORSUK, Çiğdem CERİT
Online Türk Sağlık Bilimleri Dergisi  vol: 6  issue: 4  first page: 508  year: 2021  
doi: 10.26453/otjhs.836584

25. Policy analysis: Key milestones in MDR-TB management over the past decade in South Africa
Lee-Ann C. Davids, Talitha Crowley
Journal of Public Health in Africa  vol: 15  issue: 1  year: 2024  
doi: 10.4102/jphia.v15i1.703

26. Drug Resistant Tuberculosis in the Northern Region of Zambia: A Retrospective Study
Ngula Monde, Mildred Zulu, Mathias Tembo, Ray Handema, Musso Munyeme, Sydney Malama
Frontiers in Tropical Diseases  vol: 2  year: 2021  
doi: 10.3389/fitd.2021.735028

27. Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for effective control
Isaac Darko Otchere, Adwoa Asante-Poku, Kodjo Francis Akpadja, Awa Ba Diallo, Adama Sanou, Prince Asare, Stephen Osei-Wusu, Nneka Onyejepu, Bassirou Diarra, Yaotsè Anoumou Dagnra, Aderemi Kehinde, Martin Antonio, Dorothy Yeboah-Manu
Frontiers in Public Health  vol: 12  year: 2024  
doi: 10.3389/fpubh.2024.1374703

28. Malnutrition is Associated with Delayed Sputum Culture Conversion Among Patients Treated for MDR-TB
Asnake Balche Bade, Teshale Ayele Mega, Getandale Zeleke Negera
Infection and Drug Resistance  vol: Volume 14  first page: 1659  year: 2021  
doi: 10.2147/IDR.S293461

29. Drug resistance profile of Mycobacterium tuberculosis in China: update until 2024
Yannan Xu, Sixuan Liu, Jiaxiong Zheng, Jianxiong Lin, Liwei Gi, Qiaocheng Chang
Frontiers in Microbiology  vol: 16  year: 2025  
doi: 10.3389/fmicb.2025.1697490

30. Prevalence of Drug-Resistant Tuberculosis in Sudan: A Systematic Review and Meta-Analysis
Khalid Hajissa, Mahfuza Marzan, Mubarak Ibrahim Idriss, Md Asiful Islam
Antibiotics  vol: 10  issue: 8  first page: 932  year: 2021  
doi: 10.3390/antibiotics10080932

31. Body mass index (BMI) at RR-TB diagnosis as an independent predictor of treatment outcomes: a retrospective analysis
Nonkululeko Mzinyane, Rubeshan Perumal, Lateef Babatunde Amusa, Darshan Chetty, Letitia Shunmugam, Resha Boodhram, Radhamoney Narasimmulu, Max O’Donnell, Allison Wolf, Nesri Padayatchi, Kogieleum Naidoo
BMC Infectious Diseases  vol: 26  issue: 1  year: 2026  
doi: 10.1186/s12879-026-13121-z

32. Prevalence of Intestinal Helminth Coinfection in Drug-Resistant Tuberculosis in Uganda
Joseph Baruch Baluku, Bridget Nakazibwe, Amir Wasswa, Joshua Naloka, Samuel Ntambi, Damalie Waiswa, Mark Okwir, Martin Nabwana, Felix Bongomin, Richard Katuramu, Edwin Nuwagira, Kauthrah Ntabadde, Paul Katongole, Catherine Senyimba, Irene Andia-Biraro
Open Forum Infectious Diseases  vol: 9  issue: 10  year: 2022  
doi: 10.1093/ofid/ofac541

33. The Effect of HIV and Antiretroviral Therapy on Drug-Resistant Tuberculosis Treatment Outcomes in Eastern Cape, South Africa: A Cohort Study
Brittney van de Water, Nadia Abuelezam, Jenny Hotchkiss, Mandla Botha, Limpho Ramangoaela
Viruses  vol: 15  issue: 11  first page: 2242  year: 2023  
doi: 10.3390/v15112242

34. Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting
T. I. Armina Padmasawitri, Ahmad Fuady
International Journal of Technology Assessment in Health Care  vol: 38  issue: 1  year: 2022  
doi: 10.1017/S0266462322000241

35. Sensitivity and specificity of the mean corpuscular volume and CD4/CD8 ratio in discriminating between rifampicin resistant and rifampicin sensitive tuberculosis
Joseph Baruch Baluku, Joseph Musaazi, Rose Mulwana, Derrick Bengo, Christine Sekaggya Wiltshire, Irene Andia-Biraro
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases  vol: 21  first page: 100205  year: 2020  
doi: 10.1016/j.jctube.2020.100205

36. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial
Tsegahun Manyazewal, Yimtubezinash Woldeamanuel, David P. Holland, Abebaw Fekadu, Henry M. Blumberg, Vincent C. Marconi
Trials  vol: 21  issue: 1  year: 2020  
doi: 10.1186/s13063-020-04324-z

37. Factors associated with survival of tuberculosis patients in Southeast Iran: comparison of stepwise cox regression, survival tree, and random survival forest
Mehdi Sharafi, Sakineh Narouee, Feizorrahman Rasoulizadeh, Maryam TalebiMoghaddam, Jamileh Dadgar, Mohsen Khaleghi, Abdoljabbar Zakeri, Najibullah Baeradeh
BMC Public Health  vol: 25  issue: 1  year: 2025  
doi: 10.1186/s12889-025-24603-1

38. Field evaluation of nanopore targeted next-generation sequencing to predict drug-resistant tuberculosis from native sputum in South Africa and Zambia
Tiana C. Schwab, Lavania Joseph, Andrew Moono, Pauline C. Göller, Mamello Motsei, Guy Muula, Denise Evans, Stefan Neuenschwander, Gunar Günther, Carolyn Bolton, Peter M. Keller, Alban Ramette, Matthias Egger, Shaheed V. Omar, Lukas Fenner, Christine Y. Turenne
Journal of Clinical Microbiology  vol: 63  issue: 3  year: 2025  
doi: 10.1128/jcm.01390-24

39. In vitro phytochemical, antioxidant activity and antimycobacterial potentials of selected medicinal plants commonly used for respiratory infections and related symptoms in the Limpopo Province, South Africa
Maphuti S. Matlala, Kgabo L. M. Moganedi, Peter Masoko
BMC Complementary Medicine and Therapies  vol: 25  issue: 1  year: 2025  
doi: 10.1186/s12906-025-05002-w